世界の精密がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Precision Cancer Therapies Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4743 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、精密がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、免疫療法、標的療法、モノクローナル抗体療法、遺伝子療法）、用途別市場規模（病院、診断センター、腫瘍クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・精密がん治療の市場動向 ・企業の競争状況、市場シェア ・精密がん治療の種類別市場規模（ホルモン療法、免疫療法、標的療法、モノクローナル抗体療法、遺伝子療法） ・精密がん治療の用途別市場規模（病院、診断センター、腫瘍クリニック、研究機関） ・精密がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・精密がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・精密がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・精密がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・精密がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Bayer HealthCare、GlaxoSmithKline、OncoGenex Pharmaceuticals、Hospira、Boehringer Ingelheim、AstraZeneca、Aveo Pharmaceuticals） ・結論

Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.
Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in the tumor’s genome.

Market Analysis and Insights: Global Precision Cancer Therapies Market
The global Precision Cancer Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Precision Cancer Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Precision Cancer Therapies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Precision Cancer Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Precision Cancer Therapies market.

Global Precision Cancer Therapies Scope and Market Size
Precision Cancer Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Precision Cancer Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy

Segment by Application
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormone Therapy
1.2.3 Immunotherapies
1.2.4 Targeted Therapy
1.2.5 Monoclonal Antibody Therapy
1.2.6 Gene Therapy
1.3 Market by Application
1.3.1 Global Precision Cancer Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Oncology Clinics
1.3.5 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Precision Cancer Therapies Market Perspective (2016-2027)
2.2 Precision Cancer Therapies Growth Trends by Regions
2.2.1 Precision Cancer Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Precision Cancer Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Precision Cancer Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Precision Cancer Therapies Industry Dynamic
2.3.1 Precision Cancer Therapies Market Trends
2.3.2 Precision Cancer Therapies Market Drivers
2.3.3 Precision Cancer Therapies Market Challenges
2.3.4 Precision Cancer Therapies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Therapies Players by Revenue
3.1.1 Global Top Precision Cancer Therapies Players by Revenue (2016-2021)
3.1.2 Global Precision Cancer Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Precision Cancer Therapies Revenue
3.4 Global Precision Cancer Therapies Market Concentration Ratio
3.4.1 Global Precision Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapies Revenue in 2020
3.5 Precision Cancer Therapies Key Players Head office and Area Served
3.6 Key Players Precision Cancer Therapies Product Solution and Service
3.7 Date of Enter into Precision Cancer Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Precision Cancer Therapies Breakdown Data by Type
4.1 Global Precision Cancer Therapies Historic Market Size by Type (2016-2021)
4.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2022-2027)

5 Precision Cancer Therapies Breakdown Data by Application
5.1 Global Precision Cancer Therapies Historic Market Size by Application (2016-2021)
5.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Precision Cancer Therapies Market Size (2016-2027)
6.2 North America Precision Cancer Therapies Market Size by Type
6.2.1 North America Precision Cancer Therapies Market Size by Type (2016-2021)
6.2.2 North America Precision Cancer Therapies Market Size by Type (2022-2027)
6.2.3 North America Precision Cancer Therapies Market Size by Type (2016-2027)
6.3 North America Precision Cancer Therapies Market Size by Application
6.3.1 North America Precision Cancer Therapies Market Size by Application (2016-2021)
6.3.2 North America Precision Cancer Therapies Market Size by Application (2022-2027)
6.3.3 North America Precision Cancer Therapies Market Size by Application (2016-2027)
6.4 North America Precision Cancer Therapies Market Size by Country
6.4.1 North America Precision Cancer Therapies Market Size by Country (2016-2021)
6.4.2 North America Precision Cancer Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Precision Cancer Therapies Market Size (2016-2027)
7.2 Europe Precision Cancer Therapies Market Size by Type
7.2.1 Europe Precision Cancer Therapies Market Size by Type (2016-2021)
7.2.2 Europe Precision Cancer Therapies Market Size by Type (2022-2027)
7.2.3 Europe Precision Cancer Therapies Market Size by Type (2016-2027)
7.3 Europe Precision Cancer Therapies Market Size by Application
7.3.1 Europe Precision Cancer Therapies Market Size by Application (2016-2021)
7.3.2 Europe Precision Cancer Therapies Market Size by Application (2022-2027)
7.3.3 Europe Precision Cancer Therapies Market Size by Application (2016-2027)
7.4 Europe Precision Cancer Therapies Market Size by Country
7.4.1 Europe Precision Cancer Therapies Market Size by Country (2016-2021)
7.4.2 Europe Precision Cancer Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Therapies Market Size (2016-2027)
8.2 Asia-Pacific Precision Cancer Therapies Market Size by Type
8.2.1 Asia-Pacific Precision Cancer Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Precision Cancer Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Precision Cancer Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Precision Cancer Therapies Market Size by Application
8.3.1 Asia-Pacific Precision Cancer Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Precision Cancer Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Precision Cancer Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Precision Cancer Therapies Market Size by Region
8.4.1 Asia-Pacific Precision Cancer Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Precision Cancer Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Precision Cancer Therapies Market Size (2016-2027)
9.2 Latin America Precision Cancer Therapies Market Size by Type
9.2.1 Latin America Precision Cancer Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Precision Cancer Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Precision Cancer Therapies Market Size by Type (2016-2027)
9.3 Latin America Precision Cancer Therapies Market Size by Application
9.3.1 Latin America Precision Cancer Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Precision Cancer Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Precision Cancer Therapies Market Size by Application (2016-2027)
9.4 Latin America Precision Cancer Therapies Market Size by Country
9.4.1 Latin America Precision Cancer Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Precision Cancer Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Therapies Market Size (2016-2027)
10.2 Middle East & Africa Precision Cancer Therapies Market Size by Type
10.2.1 Middle East & Africa Precision Cancer Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Precision Cancer Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Precision Cancer Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Precision Cancer Therapies Market Size by Application
10.3.1 Middle East & Africa Precision Cancer Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Precision Cancer Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Precision Cancer Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Precision Cancer Therapies Market Size by Country
10.4.1 Middle East & Africa Precision Cancer Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Precision Cancer Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Precision Cancer Therapies Introduction
11.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Bayer HealthCare
11.2.1 Bayer HealthCare Company Details
11.2.2 Bayer HealthCare Business Overview
11.2.3 Bayer HealthCare Precision Cancer Therapies Introduction
11.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2016-2021)
11.2.5 Bayer HealthCare Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction
11.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 OncoGenex Pharmaceuticals
11.4.1 OncoGenex Pharmaceuticals Company Details
11.4.2 OncoGenex Pharmaceuticals Business Overview
11.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction
11.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2016-2021)
11.4.5 OncoGenex Pharmaceuticals Recent Development
11.5 Hospira
11.5.1 Hospira Company Details
11.5.2 Hospira Business Overview
11.5.3 Hospira Precision Cancer Therapies Introduction
11.5.4 Hospira Revenue in Precision Cancer Therapies Business (2016-2021)
11.5.5 Hospira Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction
11.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Precision Cancer Therapies Introduction
11.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Aveo Pharmaceuticals
11.8.1 Aveo Pharmaceuticals Company Details
11.8.2 Aveo Pharmaceuticals Business Overview
11.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction
11.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2016-2021)
11.8.5 Aveo Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Precision Cancer Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormone Therapy
Table 3. Key Players of Immunotherapies
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Monoclonal Antibody Therapy
Table 6. Key Players of Gene Therapy
Table 7. Global Precision Cancer Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Precision Cancer Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Precision Cancer Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Precision Cancer Therapies Market Share by Regions (2016-2021)
Table 11. Global Precision Cancer Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Precision Cancer Therapies Market Share by Regions (2022-2027)
Table 13. Precision Cancer Therapies Market Trends
Table 14. Precision Cancer Therapies Market Drivers
Table 15. Precision Cancer Therapies Market Challenges
Table 16. Precision Cancer Therapies Market Restraints
Table 17. Global Precision Cancer Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Precision Cancer Therapies Market Share by Players (2016-2021)
Table 19. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Therapies as of 2020)
Table 20. Ranking of Global Top Precision Cancer Therapies Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Precision Cancer Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Precision Cancer Therapies Product Solution and Service
Table 24. Date of Enter into Precision Cancer Therapies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Precision Cancer Therapies Revenue Market Share by Type (2016-2021)
Table 28. Global Precision Cancer Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Precision Cancer Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Precision Cancer Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Precision Cancer Therapies Revenue Market Share by Application (2016-2021)
Table 32. Global Precision Cancer Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Precision Cancer Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Precision Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Precision Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Precision Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Precision Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Precision Cancer Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Precision Cancer Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Precision Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Precision Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Precision Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Precision Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Precision Cancer Therapies Product
Table 67. Abbott Laboratories Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Bayer HealthCare Company Details
Table 70. Bayer HealthCare Business Overview
Table 71. Bayer HealthCare Precision Cancer Therapies Product
Table 72. Bayer HealthCare Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million)
Table 73. Bayer HealthCare Recent Development
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Precision Cancer Therapies Product
Table 77. GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. OncoGenex Pharmaceuticals Company Details
Table 80. OncoGenex Pharmaceuticals Business Overview
Table 81. OncoGenex Pharmaceuticals Precision Cancer Therapies Product
Table 82. OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million)
Table 83. OncoGenex Pharmaceuticals Recent Development
Table 84. Hospira Company Details
Table 85. Hospira Business Overview
Table 86. Hospira Precision Cancer Therapies Product
Table 87. Hospira Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million)
Table 88. Hospira Recent Development
Table 89. Boehringer Ingelheim Company Details
Table 90. Boehringer Ingelheim Business Overview
Table 91. Boehringer Ingelheim Precision Cancer Therapies Product
Table 92. Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million)
Table 93. Boehringer Ingelheim Recent Development
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Precision Cancer Therapies Product
Table 97. AstraZeneca Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million)
Table 98. AstraZeneca Recent Development
Table 99. Aveo Pharmaceuticals Company Details
Table 100. Aveo Pharmaceuticals Business Overview
Table 101. Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million)
Table 102. Aveo Pharmaceuticals Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Therapies Market Share by Type: 2020 VS 2027
Figure 2. Hormone Therapy Features
Figure 3. Immunotherapies Features
Figure 4. Targeted Therapy Features
Figure 5. Monoclonal Antibody Therapy Features
Figure 6. Gene Therapy Features
Figure 7. Global Precision Cancer Therapies Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Oncology Clinics Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Precision Cancer Therapies Report Years Considered
Figure 13. Global Precision Cancer Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Precision Cancer Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Precision Cancer Therapies Market Share by Regions: 2020 VS 2027
Figure 16. Global Precision Cancer Therapies Market Share by Regions (2022-2027)
Figure 17. Global Precision Cancer Therapies Market Share by Players in 2020
Figure 18. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Therapies as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Precision Cancer Therapies Revenue in 2020
Figure 20. Global Precision Cancer Therapies Revenue Market Share by Type (2016-2021)
Figure 21. Global Precision Cancer Therapies Revenue Market Share by Type (2022-2027)
Figure 22. North America Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Precision Cancer Therapies Market Share by Type (2016-2027)
Figure 24. North America Precision Cancer Therapies Market Share by Application (2016-2027)
Figure 25. North America Precision Cancer Therapies Market Share by Country (2016-2027)
Figure 26. United States Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Precision Cancer Therapies Market Share by Type (2016-2027)
Figure 30. Europe Precision Cancer Therapies Market Share by Application (2016-2027)
Figure 31. Europe Precision Cancer Therapies Market Share by Country (2016-2027)
Figure 32. Germany Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Precision Cancer Therapies Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Precision Cancer Therapies Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Precision Cancer Therapies Market Share by Region (2016-2027)
Figure 42. China Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Precision Cancer Therapies Market Share by Type (2016-2027)
Figure 50. Latin America Precision Cancer Therapies Market Share by Application (2016-2027)
Figure 51. Latin America Precision Cancer Therapies Market Share by Country (2016-2027)
Figure 52. Mexico Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Precision Cancer Therapies Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Precision Cancer Therapies Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Precision Cancer Therapies Market Share by Country (2016-2027)
Figure 58. Turkey Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Laboratories Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021)
Figure 62. Bayer HealthCare Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021)
Figure 64. OncoGenex Pharmaceuticals Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021)
Figure 65. Hospira Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021)
Figure 68. Aveo Pharmaceuticals Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---